Sahay Lab is engineering lipid-based nanoparticles for delivery of mRNA based therapeutics
Researchers have designed an #mRNA vaccine that delayed the onset of and reduced the severity of multiple sclerosis-like disease in mice. The vaccine restores the body’s tolerance to its own proteins, suppressing the disease's immune overreactivity. https://fcld.ly/q0og0a2
A platform to solve for healthcare concerns troubling populace of the South Asia Region #HealthTech #vaccines #india @PMOIndia @CMOHimachal @sahayg1
Early in the pandemic I told my friend and serial entrepreneur Vishal who has started several companies and founder of Shoolini University that we need to unleash the power of mRNA in India. In these majestic hills we now manufacture mRNA. Congratulations Vishal+team RNAvaxBio.
As India becomes a backbone for the global health industry, we are delighted to launch a pioneering mRNA co. RNAVaxBio. The aim it to solve India’s health concerns.
Inline with Hon. PM Shri Modi ji’s vision of making India the Pharma hub of the world.
Today, FDA approved the first COVID-19 vaccine for the prevention of #COVID19 disease in individuals 16 years of age and older.
FDA Approves First COVID-19 Vaccine
FDA approved the first COVID-19 vaccine, now marketed as Comirnaty, for the prevention of COVID-19 disease in individuals 16 years of age and older.
Continuing with a talk by our Young Investigator Award Winner @VaderPieter! Join us if you'd like to know if exosomes are better than synthetic nanocarriers at delivering nucleic acids!